<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PSA Rising Prostate Cancer Blog &#187; jacquie strax</title>
	<atom:link href="http://www.psa-rising.com/blog/author/jacquie/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.psa-rising.com/blog</link>
	<description></description>
	<lastBuildDate>Tue, 16 Aug 2011 09:39:00 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Provenge available for men with advanced prostate cancer at Roswell Park</title>
		<link>http://www.psa-rising.com/blog/2011/02/provenge-available-for-men-with-advanced-pca-at-roswell-park/</link>
		<comments>http://www.psa-rising.com/blog/2011/02/provenge-available-for-men-with-advanced-pca-at-roswell-park/#comments</comments>
		<pubDate>Wed, 16 Feb 2011 00:39:59 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Hormone refractory]]></category>
		<category><![CDATA[Immunotherapy]]></category>
		<category><![CDATA[Metastatic]]></category>
		<category><![CDATA[PCa Treatments]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Provenge]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Add new tag]]></category>
		<category><![CDATA[Advanced PCa]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2368</guid>
		<description><![CDATA[February 7 2011, BUFFALO, NY — The nation’s first FDA-approved cancer treatment vaccine, Provenge (sipuleucel-T), is being offered for the first time in Western New York at Roswell Park Cancer Institute (RPCI). The vaccine is designed for men with advanced prostate cancer who have limited treatment options and who meet eligibility requirements. “It’s the first [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2011/02/provenge-available-for-men-with-advanced-pca-at-roswell-park/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How does a robotic prostatectomy work?</title>
		<link>http://www.psa-rising.com/blog/2011/02/how-robotic-prostatectomy-works/</link>
		<comments>http://www.psa-rising.com/blog/2011/02/how-robotic-prostatectomy-works/#comments</comments>
		<pubDate>Tue, 15 Feb 2011 22:17:25 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Laparoscopic surgery]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Radical Prostatectomy]]></category>
		<category><![CDATA[Robotic surgery]]></category>
		<category><![CDATA[laparoscopic surgery]]></category>
		<category><![CDATA[Prostatectomy]]></category>
		<category><![CDATA[Robot-assisted Surgery]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2322</guid>
		<description><![CDATA[Robot assisted prostate surgery, known medically as the da Vinci prostatectomy, has had a profound influence over treatment during the past decade. Robotic surgical technology was first developed by the military for use in the battlefield. However during the past decade, this technology has been rapidly applied to the general medical setting, notably in the [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2011/02/how-robotic-prostatectomy-works/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dendreon Sets Provenge Price at $93,000 &#8211; Only 2,000 Patients Will Get it in First Year</title>
		<link>http://www.psa-rising.com/blog/2010/04/provenge-cost-high-availability-low/</link>
		<comments>http://www.psa-rising.com/blog/2010/04/provenge-cost-high-availability-low/#comments</comments>
		<pubDate>Fri, 30 Apr 2010 03:27:08 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Dendreon]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Provenge]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2301</guid>
		<description><![CDATA[Dendreon is pricing Provenge high and for the first year its availability will be low, according to a report today in Xconomy, a Seattle business website. Provenge, the first immunotherapy to win FDA approval for treatment of men with prostate cancer, will cost $93,000 per patient. Only 2,000 patients will be treated with Provenge in [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2010/04/provenge-cost-high-availability-low/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves PROVENGE &#174; for the Treatment of Men with Advanced Prostate Cancer</title>
		<link>http://www.psa-rising.com/blog/2010/04/fda-approves-provenger-for-the-treatment-of-men-with-advanced-prostate-cancer/</link>
		<comments>http://www.psa-rising.com/blog/2010/04/fda-approves-provenger-for-the-treatment-of-men-with-advanced-prostate-cancer/#comments</comments>
		<pubDate>Thu, 29 Apr 2010 20:24:33 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Provenge]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2297</guid>
		<description><![CDATA[SEATTLE, April 29, 2010 &#8211;Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) has approved PROVENGE(&#174;) (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer (CRPC). Provenge is designed to induce an immune response against Prostatic Acid Phosphatase (PAP), an antigen [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2010/04/fda-approves-provenger-for-the-treatment-of-men-with-advanced-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>U.S. cancer trials near state of crisis, report</title>
		<link>http://www.psa-rising.com/blog/2010/04/u-s-cancer-trials-in-crisis/</link>
		<comments>http://www.psa-rising.com/blog/2010/04/u-s-cancer-trials-in-crisis/#comments</comments>
		<pubDate>Fri, 16 Apr 2010 21:04:47 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cancer research]]></category>
		<category><![CDATA[clinical trials conduct of]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2289</guid>
		<description><![CDATA[The U.S. government’s cancer research network is in severe disarray according to a report by the Institute of Medicine. Waste and inefficiency cause 40% of all late-stage government funded cancer trials to be abandoned before completion, the report found. Shannon Pettypiece at Bloomberg.com and Liz Jones at FierceBiotech say the report paints a doomladen picture. [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2010/04/u-s-cancer-trials-in-crisis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Phase 3 Trial Underway for MDV 3100 for Advanced Prostate Cancer</title>
		<link>http://www.psa-rising.com/blog/2010/04/mdv3100-trial-phase3/</link>
		<comments>http://www.psa-rising.com/blog/2010/04/mdv3100-trial-phase3/#comments</comments>
		<pubDate>Thu, 15 Apr 2010 19:58:54 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Clinical trials]]></category>
		<category><![CDATA[MDV 3100]]></category>
		<category><![CDATA[Metastatic]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[trial results]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2280</guid>
		<description><![CDATA[In light of favorable results from the Phase 1-2 trial of MDV 3100 for advanced prostate cancer, a Phase 3 trial is enrolling at sites in the US, Canada, South America, UK, Europe, Australia, and South Africa. Results from the earlier trial are published online by the UK medical journal The Lancet. Phase 3 Trial [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2010/04/mdv3100-trial-phase3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Mural for a Cancer Patient Tells a Story of Broken Healthcare</title>
		<link>http://www.psa-rising.com/blog/2009/11/a-mural-for-a-cancer-patient/</link>
		<comments>http://www.psa-rising.com/blog/2009/11/a-mural-for-a-cancer-patient/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 22:39:03 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Awareness Events]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Healthcare Reform]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2229</guid>
		<description><![CDATA[Regina Holliday has painted a mural on the side of a gas station in Washington DC to tell the story of a day in her husband Fred&#8217;s struggle with broken healthcare. At ge 39, Fred was diagnosed with stage IV kidney cancer. Fred and Regina&#8217;s story has been covered by AOL, local ABC TV and [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/11/a-mural-for-a-cancer-patient/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Free Prostate Screening in Seattle November 20</title>
		<link>http://www.psa-rising.com/blog/2009/11/2207/</link>
		<comments>http://www.psa-rising.com/blog/2009/11/2207/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 08:13:13 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Prostate Cancer]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/2009/11/2207/</guid>
		<description><![CDATA[Seattle Prostate Institute, an affiliate of Swedish Cancer Institute, is offering free prostate cancer screening tests on Fri., Nov. 20 between 8 a.m. and 3:30 p.m. at their offices in the 1101 Madison Medical Tower, Suite 1101, on the Swedish/First Hill Campus. This complimentary screening – which is recommended for men 50 or older and [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/11/2207/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ASTRO Prostate Cancer News Headlines Preview</title>
		<link>http://www.psa-rising.com/blog/2009/10/astro-prostate-cancer-preview/</link>
		<comments>http://www.psa-rising.com/blog/2009/10/astro-prostate-cancer-preview/#comments</comments>
		<pubDate>Sat, 31 Oct 2009 11:05:58 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Beam Radiation]]></category>
		<category><![CDATA[PCa Treatments]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Proton]]></category>
		<category><![CDATA[ASTRO]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2199</guid>
		<description><![CDATA[The American Society for Radiation Oncology (ASTRO) will host news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting to be held this coming week in Chicago. Prostate cancer features in three of briefings. Here are the headlines: News briefing 1: Monday, November 2, at 8:00 a.m. (Central); [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/10/astro-prostate-cancer-preview/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Obama Orders Medical Marijuana Use Allowed Where State Law Makes it Legal</title>
		<link>http://www.psa-rising.com/blog/2009/10/feds-halt-medical-marijuana-prosectutions/</link>
		<comments>http://www.psa-rising.com/blog/2009/10/feds-halt-medical-marijuana-prosectutions/#comments</comments>
		<pubDate>Mon, 19 Oct 2009 17:59:19 +0000</pubDate>
		<dc:creator>jacquie strax</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[medical marijuana]]></category>
		<category><![CDATA[Pres. Barack Obama]]></category>

		<guid isPermaLink="false">http://www.psa-rising.com/blog/?p=2187</guid>
		<description><![CDATA[The Obama administration has changed Federal policies on regulation of medical marijuana use under state law. During his presidential race last year, Barack Obama said that he intended to halt raids of medical marijuana facilities operating legally under state laws. Today, new Justice Department guidelines brought this change about. The new guidelines order federal drug [...]]]></description>
		<wfw:commentRss>http://www.psa-rising.com/blog/2009/10/feds-halt-medical-marijuana-prosectutions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

